Cargando…
Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis
BACKGROUND: Pulmonary fibrosis is one of the sequelae of the COVID-19, which seriously affects the quality of life of survivors. Currently, there are no optimal evidence based guidelines targeting this population. CASE PRESENTATION: We report a 66-year-old female patient without underlying comorbidi...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207265/ https://www.ncbi.nlm.nih.gov/pubmed/35733875 http://dx.doi.org/10.3389/fmed.2022.925703 |